by The U.S. precision medicine market size is poised to grow by USD 75.44 billion by 2033 from USD 24.84 billion in 2023, exhibiting a CAGR of 11.80% during the forecast period 2024 to 2033.
Key Takeaways
- By technology, the drug discovery segment held the dominating share of the market in 2023.
- By application, the oncology segment dominated the U.S. precision medicine market in 2023.
- By end-use, the pharmaceutical company segment held the largest share of the market in 2023.
- By sequencing technology, the single molecule real-time sequencing segment is expected to dominate the market over the forecast period.
- By product, the consumables segment held the largest share of the market in 2023.
- By route of administration, the oral segment held the largest share of the market in 2023.
- By drugs, the Mepolizumab segment is observed to witness significant growth during the forecast period.
Precedence Research has conducted a comprehensive market study that provides valuable insights into the performance of the market during the forecast period. The study identifies significant trends that are shaping the growth of the U.S. precision medicine market. In this recently published report, essential dynamics such as drivers, restraints, and opportunities are highlighted for both established market players and emerging participants involved in production and supply.
To begin with, the U.S. precision medicine Market report features an executive summary that offers a concise overview of the marketplace. It outlines the key players and industry categories expected to have an impact on the market in the coming years. The executive summary provides an unbiased summary of the market.
Get a Sample Report: https://www.precedenceresearch.com/sample/3722
U.S. Precision Medicine Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 11.80% |
| U.S. Market Size in 2023 | USD 24.84 Billion |
| U.S. Market Size by 2033 | USD 75.44 Billion |
| Base Year | 2024 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Technology, By Application, By End-Use, By Sequencing Technology, By Product, By Route of Administration, and By Drugs |
Read More: Solar Carport Market Size to Attain USD 1,173.6 Million by 2033
The empirical study on the global U.S. precision medicine market primarily focuses on the drivers in subsequent sections. It demonstrates how changing demographics are projected to influence the supply and demand dynamics in the U.S. precision medicine Market. Our market report for the U.S. precision medicine market also delves into the significant rules and regulations that are likely to impact the future growth of this sector. Moreover, in order to comprehend the underlying demand factors, industry experts have provided insights into its fundamental origins.
U.S. Precision Medicine Market Players
- Biocrates Life Sciences
- Quest Diagnostics
- NanoString Technologies
- Pfizer
- AbbVie Inc.
- AstraZeneca
- Johnson & Johnson Services, Inc
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- ARIEL Precision Medicine, Inc.
Data Sources and Methodology
To gather comprehensive insights on the Global U.S. precision medicine Market, we relied on a range of data sources and followed a well-defined methodology. Our approach involved interactions with industry experts and key stakeholders across the market’s value chain, including management organizations, processing organizations, and analytics service providers.
We followed a rigorous data analysis process to ensure the quality and credibility of our research. The gathered information was carefully evaluated, and relevant quantitative data was subjected to statistical analysis. By employing robust analytical techniques, we were able to derive meaningful insights and present a comprehensive overview of the Global U.S. precision medicine Market.
The most resonating, simple, genuine, and important causes because of which you must decide to buy the U.S. precision medicine market report exclusively from precedence research
- The research report has been meticulously crafted to provide comprehensive knowledge on essential marketing strategies and a holistic understanding of crucial marketing plans spanning the forecasted period from 2023 to 2032.
Key Features of the Report:
- Comprehensive Coverage: The report extensively encompasses a detailed explanation of highly effective analytical marketing methods applicable to companies across all industry sectors.
- Decision-Making Enhancement: It outlines a concise overview of the decision-making process while highlighting key techniques to enhance it, ensuring favorable business outcomes in the future.
- Articulated R&D Approach: The report presents a well-defined approach to conducting research and development (R&D) activities, enabling accurate data acquisition on current and future marketing conditions.
Market Segmentation:
By Technology
- Bioinformatics
- Big Data Analytics
- Drug Discovery
- Gene Sequencing
- Companion Diagnostics
- Others
By Application
- CNS
- Immunology
- Oncology
- Respiratory
- Others
By End-Use
- Diagnostic Companies
- Pharmaceutical Companies
- Healthcare IT companies
- Others
By Sequencing Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing
By Product
- Consumables
- Instruments
- Services
By Route of Administration
- Oral
- Injectable
By Drugs
- Alectinib
- Osimertinib
- Mepolizumab
- Aripiprazole Lauroxil
- Others
Reasons to Consider Purchasing the Report:
- Enhance your market research capabilities by accessing this comprehensive and precise report on the global U.S. precision medicine market.
- Gain a thorough understanding of the overall market landscape and be prepared to overcome challenges while ensuring robust growth.
- Benefit from in-depth research and analysis of the latest trends shaping the global U.S. precision medicine market.
- Obtain detailed insights into evolving market trends, current and future technologies, and strategic approaches employed by key players in the global U.S. precision medicine market.
- Receive valuable recommendations and guidance for both new entrants and established players seeking further market expansion.
- Discover not only the cutting-edge technological advancements in the global U.S. precision medicine market but also the strategic plans of industry leaders.
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global U.S. Precision Medicine Market, By Technology
7.1. U.S. Precision Medicine Market Revenue and Volume, by Technology, 2024-2033
7.1.1. Bioinformatics
7.1.1.1. Market Revenue and Volume Forecast (2021-2033)
7.1.2. Big Data Analytics
7.1.2.1. Market Revenue and Volume Forecast (2021-2033)
7.1.3. Drug Discovery
7.1.3.1. Market Revenue and Volume Forecast (2021-2033)
7.1.4. Gene Sequencing
7.1.4.1. Market Revenue and Volume Forecast (2021-2033)
7.1.5. Companion Diagnostics
7.1.6.1. Market Revenue and Volume Forecast (2021-2033)
7.1.6. Others
7.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 8. Global U.S. Precision Medicine Market, By Application
8.1. U.S. Precision Medicine Market Revenue and Volume, by Application, 2024-2033
8.1.1. CNS
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Immunology
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Oncology
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Respiratory
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global U.S. Precision Medicine Market, By End-Use
9.1. U.S. Precision Medicine Market Revenue and Volume, by End-Use, 2024-2033
9.1.1. Diagnostic Companies
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Pharmaceutical Companies
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Healthcare IT companies
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global U.S. Precision Medicine Market, By Sequencing Technology
10.1. U.S. Precision Medicine Market Revenue and Volume, by Sequencing Technology, 2024-2033
10.1.1. Sequencing by Synthesis
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Ion Semiconductor Sequencing
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Sequencing by Ligation
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Pyrosequencing
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Single Molecule Real Time Sequencing
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
10.1.6. Chain Termination Sequencing
10.1.6.1. Market Revenue and Volume Forecast (2021-2033)
10.1.7. Nanopore Sequencing
10.1.7.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global U.S. Precision Medicine Market, By Product
11.1. U.S. Precision Medicine Market Revenue and Volume, by Product, 2024-2033
11.1.1. Consumables
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Instruments
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Services
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global U.S. Precision Medicine Market, By Route of Administration
12.1. U.S. Precision Medicine Market Revenue and Volume, by Route of Administration, 2024-2033
12.1.1. Oral
12.1.1.1. Market Revenue and Volume Forecast (2021-2033)
12.1.2. Injectable
12.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 13. Global U.S. Precision Medicine Market, By Drugs
13.1. U.S. Precision Medicine Market Revenue and Volume, by Drugs, 2024-2033
13.1.1. Alectinib
13.1.1.1. Market Revenue and Volume Forecast (2021-2033)
13.1.2. Osimertinib
13.1.2.1. Market Revenue and Volume Forecast (2021-2033)
13.1.3. Mepolizumab
13.1.3.1. Market Revenue and Volume Forecast (2021-2033)
13.1.4. Aripiprazole Lauroxil
13.1.4.1. Market Revenue and Volume Forecast (2021-2033)
13.1.5. Others
13.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 14. Global U.S. Precision Medicine Market, Regional Estimates and Trend Forecast
14.1. U.S.
14.1.1. Market Revenue and Volume Forecast, by Technology (2021-2033)
14.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)
14.1.3. Market Revenue and Volume Forecast, by End-Use (2021-2033)
14.1.4. Market Revenue and Volume Forecast, by Sequencing Technology (2021-2033)
14.1.5. Market Revenue and Volume Forecast, by Product (2021-2033)
14.1.6. Market Revenue and Volume Forecast, by Drugs (2021-2033)
14.1.7. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)
Chapter 15. Company Profiles
15.1. Biocrates Life Sciences
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Quest Diagnostics
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. NanoString Technologies
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Pfizer
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. AbbVie Inc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. AstraZeneca
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Johnson & Johnson Services, Inc
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Thermo Fisher Scientific, Inc.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Illumina, Inc.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. ARIEL Precision Medicine, Inc.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Unlocking Market Insights through Data Excellence
The “Precedence Statistics” flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today’s dynamic and data-driven world.
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
Precedence Statistics – Empowering Your Data Insights
Contact Us
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
